Common variant at 16p11.2 conferring risk of psychosis

Steinberg, S, de Jong, S, Mattheisen, M, Costas, J, Demontis, D, Jamain, S, Pietiläinen, O P H, Lin, K +125 more·2014·Molecular Psychiatry
DOI 10.1038/mp.2012.157

Cited by (104)

Items 101–104 of 104

  1. 16p11.2 duplication and NMDA receptor antagonism have distinct impacts on reward learning and decision making
    Dana Mueller, Evan Knep, Angelica Velosa, Erin Giglio, Cathy S. Chen, Sarah R. Heilbronner, R. Becket Ebitz, Patrick E. Rothwell, Nicola M. Grissom · 2026 · Psychopharmacology
  2. Integrative multi-omics identifies DOC2A as a novel pharmacological target for bipolar disorder
    Chengsong Yuan, Ben Zhang, Yuanyuan Liang, Junze Ran, Shiyi Hu, Andi Liu, Yuran Liu, Fengqin Qin, Lingqi Jian, Yongji He et al. · 2026 · Psychological Medicine
  3. Complex neurodevelopmental disorders associated with 16p11.2 duplication: a case report
    Marco O. Bertelli, Annamaria Bianco, Michele Rossi, Maria Stella Vescio · 2026 · Advances in Mental Health and Intellectual Disabilities
  4. Synaptic and Circuit Mechanisms Shaping Neurodevelopmental and Psychiatric Outcomes Associated with 16p11.2 Copy Number Variation
    Alžbeta Námešná, Jasmine Pickford, Jérémy Hall, Marianne B. M. van den Bree, Luke Tait, Lawrence S. Wilkinson, Matthew W. Jones · 2026 · Genes